Text and Data Mining valid from 2019-11-07
Received: 15 August 2019
Accepted: 9 October 2019
First Online: 7 November 2019
Ethics approval and consent to participate
: The in vivo studies described in this manuscript were conducted in accordance with the requirements of the Animals (Scientific Procedures) Act 1986, and as such a local ethical review was maintained.
: JF, JS and BRS are Directors of AV7 Ltd. AV7 Limited have no competing interests to declare. K1-70™ is currently in use as part of a Phase I, Single Ascending Intramuscular or Single Intravenous Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Subjects with Graves’ Disease (IRAS ID 199697, Eudract number 2014-003815-12).